Schedule 13G ownership disclosure
INNOVUS PHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 45778V106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001798208-20-000002
- Form type
- SC 13G
- Filer
- INNOVUS PHARMACEUTICALS, INC.
- CIK
- CIK 1411879
- Filed
- Jan 15, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership